N/A N=6 Device Feasibility

Investigation of TEST (Transcranial Electric Stimulation Therapy) for Chronic Pain

Chronic Pain

Bottom Line

View on ClinicalTrials.gov: NCT05113563 ↗

Enrolled (actual)

Serious AEs

16.7%

Results posted

Apr 2025

Primary outcome: Primary: Feasibility Will be Assessed by the Percent of Participants Who Complete — 6 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Transcranial Electric Stimulation Therapy (Device)
Age: Adult · 22+ yrs
Sex: All
Sponsor: New York State Psychiatric Institute
Primary completion: Jan 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility Will be Assessed by the Percent of Participants Who Complete	6	—

Summary

The goal in this study is to investigate TEST (Transcranial Electric Stimulation Therapy) for chronic pain. It requires an inpatient stay on our research unit of about a month. The study is designed to address the cognitive and emotional aspects of chronic pain and other conditions that often accompany this disorder, such as major depression or drug use.

Eligibility Criteria

Inclusion Criteria

adults (ages 22 to 60) who understand all procedures and have the ability to provide informed consent, with a score on the Mini-Mental Status Exam of at least 24;
participants experiencing chronic pain, with ongoing pain symptoms, and score on the Brief Pain Inventory of > 5 on question #3 (which asks about maximal pain in the past 24 hours) or > 5 on question #5 (which asks about average pain in the past 24 hours);
a diagnosis of chronic postoperative pain, low back pain, musculoskeletal pain, fibromyalgia, visceral pain or neuropathic pain, including complex regional pain syndrome or peripheral neuropathy;
no significant changes in pain medications for at least one month prior to study entry.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05113563). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.